Latent autoimmune diabetes in adults in a population-based cohort of Polish patients with newly diagnosed diabetes mellitus 8. Brophy S, Brunt H, Davies H, Mannan S, Williams R. Inter- ventions for latent autoimmune diabetes (LADA) in adults. Cochrane Database Syst Rev 2007; CD006165. 9. Davies H, Mannan S, Brophy S, Williams R. Routine glu- tamic acid decarboxylase autoantibody (GADA) testing: patients' perspective. Fam Pract 2008; 25: 176-80. 10. Desai M, Cull CA, Horton VA, et al. GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77. Diabetologia 2007; 50: 2052-60. 11. Palmer JP, Asplin CM, Clemons P, et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983; 222: 1337-9. 12. Hummel M, Bonifacio E, Schmid S, Walter M, Knopff A, Ziegler AG. Brief communication: early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic parents. Ann Intern Med 2004; 140: 882-6. 13. Eisenbarth GS, Moriyama H, Robles DT, et al. Insulin autoimmunity: prediction/precipitation/prevention type 1A diabetes. Autoimmun Rev 2002; 1: 139-45. 14. Huang G, Wang X, Li Z, Li H, Li X, Zhou Z. Insulin autoan- tibody could help to screen latent autoimmune diabetes in adults in phenotypic type 2 diabetes mellitus in Chi- nese. Acta Diabetol 2010 May 16. [Epub ahead of print]. 15. Ruige JB, Batstra MR, Aanstoot HJ, et al. Low prevalence of antibodies to GAD65 in a 50- to 74-year-old general Dutch population. The Hoorn Study. Diabetes Care 1997; 20: 1108-10. 16. Carlsson A, Sundkvist G, Groop L, Tuomi T. Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA). J Clin Endocrinol Metab 2000; 85: 76-80. 17. Stenstrom G, Gottsater A, Bakhtadze E, Berger B, Sund- kvist G. Latent autoimmune diabetes in adults: definition, prevalence, beta-cell function, and treatment. Diabetes 2005; 54 Suppl 2: S68-72. 18. van Deutekom AW, Heine RJ, Simsek S. The islet autoan- tibody titres: their clinical relevance in latent autoimmune diabetes in adults (LADA) and the classification of dia- betes mellitus. Diabet Med 2008; 25: 117-25. 19. Williams AJ, Norcross AJ, Dix RJ, Gillespie KM, Gale EA, Bin- gley PJ. The prevalence of insulin autoantibodies at the onset of Type 1 diabetes is higher in males than females during adolescence. Diabetologia 2003; 46: 1354-6. 20. Szurkowska M, Szybinski Z, Nazim A, Szafraniec K, Jedrychowski W. Prevalence of type II diabetes mellitus in population of Krakow [Polish]. Pol Arch Med Wewn 2001; 106: 771-9. 21. Berger B, Borg H, Fernlund P, Stenstrom G, Sundkvist G. Islet antibodies associated with pancreatic B-cell dys- function at and 3 years after diagnosis of diabetes in sub- jects aged 35-64 years old: degree of impairment less severe than in those aged 0-34 years old. Diabet Med 2006; 23: 1180-5. Arch Med Sci 3, June / 2012 495